Bain Capital, LP is one of the world’s leading private investment firms with approximately $160 billion of assets under management that creates lasting impact for our investors, teams, businesses, and the communities in which we live. Since our founding in 1984, we’ve applied our insight and experience to organically expand into several asset classes including private equity, credit, public equity, venture capital and real estate. We leverage our shared platform to capture cross-asset class opportunities in strategic areas of focus. With offices on four continents, our global team aligns our interests with those of our investors for lasting impact.

Bain Capital Investor Portal Please log in to access your account information. If you have any questions regarding your account, please contact

Polly Gabrieli

Polly Gabrieli

Life Sciences


Ms. Gabrieli joined Bain Capital Life Sciences in 2022 as an analyst. She was previously a Bain Capital Life Sciences fellow. 

Prior to joining Bain Capital, Ms. Gabrieli was a master's student researcher at the Department of Biomedical Informatics at Harvard Medical School, where she studied the genomic and clinical correlates of response to immunotherapy.


Ms. Gabrieli graduated summa cum laude from Harvard College with a BA in Neuroscience. She received her MS in Biomedical Informatics from Harvard Medical School.